HSP90AA1 and prostate carcinoma: Additionally, Sansalvamide A-amide (San A-amide) serves as a small molecule inhibitor of Hsp90, binding between the NTD and the MD to disrupt their functions in various cancers, including pancreatic, colon, breast, and prostate cancers, both in vivo and in vitro [192].